Schlieper, G., Remppis, A., Schwenger, V., Keller, T., Dechend, R., Massberg, S., Baldus, S., Weinreich, T., Hetzel, G., Floege, J., Hoyer, J., Mahfoud, F. and Fliser, D. (2018). Non-vitamin K antagonist oral anticoagulants (NOAC) in chronic kidney disease. Recommendations of the working group Heart-Kidneys, of the German Cardiac Society and the German Society of Nephrology. Nephrologe, 13 (2). S. 91 - 99. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1862-0418

Full text not available from this repository.

Abstract

Non-vitamin K antagonist oral anticoagulants (NOAC) are administered for stroke prophylaxis in patients with atrial fibrillation and corresponding risk scores. In addition, NOAC are used for treatment and prophylaxis of venous thromboembolic events, such as deep vein thrombosis and acute pulmonary embolism and their prophylaxis in recurrent events. Clinical trials have excluded patients with advanced chronic kidney disease; therefore, data cannot always be generalized to patients with chronic kidney disease. The use of NOAC is not recommended or is contraindicated in advanced stages of chronic kidney disease.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Schlieper, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Remppis, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schwenger, V.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Keller, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dechend, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Massberg, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Baldus, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Weinreich, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hetzel, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Floege, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hoyer, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mahfoud, F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Fliser, D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-193597
DOI: 10.1007/s11560-018-0230-x
Journal or Publication Title: Nephrologe
Volume: 13
Number: 2
Page Range: S. 91 - 99
Date: 2018
Publisher: SPRINGER HEIDELBERG
Place of Publication: HEIDELBERG
ISSN: 1862-0418
Language: German
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
ATRIAL-FIBRILLATION PATIENTS; STAGE RENAL-DISEASE; DEEP-VEIN THROMBOSIS; ANTITHROMBOTIC THERAPY; MORTALITY RISK; WARFARIN USE; STROKE; RIVAROXABAN; SAFETY; PHARMACOKINETICSMultiple languages
Urology & NephrologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/19359

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item